JP2004502454A5 - - Google Patents

Download PDF

Info

Publication number
JP2004502454A5
JP2004502454A5 JP2002509461A JP2002509461A JP2004502454A5 JP 2004502454 A5 JP2004502454 A5 JP 2004502454A5 JP 2002509461 A JP2002509461 A JP 2002509461A JP 2002509461 A JP2002509461 A JP 2002509461A JP 2004502454 A5 JP2004502454 A5 JP 2004502454A5
Authority
JP
Japan
Prior art keywords
human
cell line
producing
cells
myeloma cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002509461A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502454A (ja
Filing date
Publication date
Priority claimed from GB0016824A external-priority patent/GB0016824D0/en
Priority claimed from GB0017139A external-priority patent/GB0017139D0/en
Application filed filed Critical
Priority claimed from PCT/GB2001/003059 external-priority patent/WO2002004607A1/en
Publication of JP2004502454A publication Critical patent/JP2004502454A/ja
Publication of JP2004502454A5 publication Critical patent/JP2004502454A5/ja
Withdrawn legal-status Critical Current

Links

JP2002509461A 2000-07-07 2001-07-09 ヒト骨髄腫細胞系 Withdrawn JP2004502454A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0016824A GB0016824D0 (en) 2000-07-07 2000-07-07 Human monoclonal antibodies
GB0017139A GB0017139D0 (en) 2000-07-12 2000-07-12 Human monoclonal antibodies
US27058801P 2001-02-23 2001-02-23
PCT/GB2001/003059 WO2002004607A1 (en) 2000-07-07 2001-07-09 Human myeloma cell line

Publications (2)

Publication Number Publication Date
JP2004502454A JP2004502454A (ja) 2004-01-29
JP2004502454A5 true JP2004502454A5 (enExample) 2008-07-31

Family

ID=27255800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002509461A Withdrawn JP2004502454A (ja) 2000-07-07 2001-07-09 ヒト骨髄腫細胞系

Country Status (12)

Country Link
US (1) US7387873B2 (enExample)
EP (1) EP1299524B1 (enExample)
JP (1) JP2004502454A (enExample)
KR (1) KR20030022850A (enExample)
CN (1) CN100497601C (enExample)
AT (1) ATE440945T1 (enExample)
AU (2) AU2001269300B2 (enExample)
CA (1) CA2415484A1 (enExample)
DE (1) DE60139694D1 (enExample)
IL (1) IL153641A0 (enExample)
NO (1) NO20030019L (enExample)
WO (1) WO2002004607A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001269300B2 (en) 2000-07-07 2006-06-22 Cambridge University Technical Services Limited Human myeloma cell line
WO2003052082A2 (en) 2001-12-18 2003-06-26 Whitehead Institute For Biomedical Research Fusion partner cells and uses thereof
US20110070358A1 (en) 2009-09-20 2011-03-24 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
US8381774B2 (en) * 2009-09-20 2013-02-26 Medtronic Vascular, Inc. Methods for loading a drug eluting medical device
US8678046B2 (en) 2009-09-20 2014-03-25 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
US8333801B2 (en) 2010-09-17 2012-12-18 Medtronic Vascular, Inc. Method of Forming a Drug-Eluting Medical Device
CN105601734A (zh) * 2016-03-01 2016-05-25 广东医学院附属医院 一种从人外周血记忆性b淋巴细胞制备抗体的方法
CN115161311B (zh) * 2022-08-22 2025-05-06 广东忠信生物科技有限公司 高效筛选分泌单克隆抗体的杂交瘤细胞的方法及其应用
CN115463146B (zh) * 2022-10-14 2024-01-23 浙大城市学院 哇巴因化合物作为在制备抗病毒药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096839B1 (en) * 1982-06-09 1989-01-25 Asahi Kasei Kogyo Kabushiki Kaisha Method for producing human antibody
US4720459A (en) * 1985-02-14 1988-01-19 Medical College Of Wisconsin Research Foundation, Inc. Myelomas for producing human/human hybridomas
AU2001269300B2 (en) 2000-07-07 2006-06-22 Cambridge University Technical Services Limited Human myeloma cell line

Similar Documents

Publication Publication Date Title
EP0182467B1 (en) Human hybridoma fusion partner for production of human monoclonal antibodies
CA2056102C (en) Method for the production of antibodies
US4451570A (en) Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
CA1315715C (en) Human cell line and triomas, antibodies, and transformants derived therefrom
JPH0789909B2 (ja) ハイブリドーマセルラインの製造法
US5114847A (en) Process for the production of permanently culturable animal and human cell lines and the use thereof
JP2004502454A5 (enExample)
EP2009094B1 (en) Fusion partner cells
KR20030022850A (ko) 인간 골수종 세포주
Abrams et al. [10] Optimal strategies for developing human—human monoclonal antibodies
WO2008013552A2 (en) Fully human hybridoma fusion partner cell lines
JP2764101B2 (ja) ヒトハイブリドーマ作製用の親細胞株
US4833077A (en) Method for producing human antibody
James Human monoclonal antibody technology
WO1989000607A1 (en) Preparation of human monoclonal antibodies of selected specificity and isotypes
JPH0551277B2 (enExample)
JP3043023B2 (ja) ハイブリドーマ
Maryanski et al. A simple panning method for the selection of cell surface antigen transfectants
JPS6239999B2 (enExample)
Asmussen-Speck T Cell Influence on the Secondary B Cell Repertoire
JPS63185374A (ja) ヒト−ヒトハイブリド−マ作製用親細胞株
JPH03297382A (ja) ヒト―ヒトハイブリドーマ作製用親細胞株及びその取得方法